Abvc Biopharma Inc
(ABVC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2010 | 12-2009 | 09-2009 | 06-2009 | 03-2009 | |
| Assets | |||||
| Current Assets | |||||
| Other current assets | 0 | 0 | 1 | 0 | 0 |
| TOTAL | $N/A | $N/A | $1 | $N/A | $N/A |
| Non-Current Assets | |||||
| PPE Net | N/A | N/A | 110 | N/A | N/A |
| Other Non-Current Assets | 0 | 0 | 450 | 0 | 0 |
| TOTAL | $N/A | $N/A | $560 | $N/A | $N/A |
| Total Assets | $N/A | $N/A | $510 | $N/A | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 0 | 0 | 1,270 | 0 | 0 |
| Accrued Expenses | N/A | N/A | 70 | N/A | N/A |
| Other current liabilities | N/A | N/A | 340 | N/A | N/A |
| TOTAL | $N/A | $N/A | $2,520 | $N/A | $N/A |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $N/A | $N/A | $2,520 | $N/A | $N/A |
| Shareholders' Equity | |||||
| Common Shares | N/A | N/A | 30 | N/A | N/A |
| Retained earnings | N/A | N/A | -22,680 | N/A | N/A |
| TOTAL | $N/A | $N/A | $-2,010 | $N/A | $N/A |
| Total Liabilities And Equity | $0 | $0 | $510 | $0 | $0 |